China Universal Asset Management Co., Ltd. Arbutus Biopharma Corp Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 36,309 shares of ABUS stock, worth $115,825. This represents 0.02% of its overall portfolio holdings.
Number of Shares
36,309
Previous 22,171
63.77%
Holding current value
$115,825
Previous $68,000
104.41%
% of portfolio
0.02%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding ABUS
# of Institutions
155Shares Held
99.5MCall Options Held
2.31MPut Options Held
525K-
Morgan Stanley New York, NY21.7MShares$69.2 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY12.9MShares$41 Million26.34% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$36.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.92MShares$28.5 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY8.39MShares$26.8 Million10.86% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $478M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...